Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-033206

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2017M1,549$0.00A103,741D
Common StockF1May 15, 2017M817$0.00A104,558D
Common StockMay 16, 2017S1,184$15.25D103,374D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—May 15, 2017M1,549D——Common Stock1,5494,645D
Restricted Stock UnitsF3,F6,F7—May 15, 2017M817D——Common Stock8172,997D

Explanation of responses